+ Translate

Estimating vaccine efficacy in prospective studies

, : Estimating vaccine efficacy in prospective studies. Preventive Veterinary Medicine 20(4): 279-296

This paper discusses vaccine efficacy assessment and reviews interval estimation methods for summary measures from clinical trials and cohort studies of a protective exposure.

Accession: 002373064

DOI: 10.1016/0167-5877(94)90061-2

Download PDF Full Text: Estimating vaccine efficacy in prospective studies

Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:

Related references

Rahman, M.Shafiqur., 2013: Estimating vaccine efficacy under the heterogeneity of vaccine action in a nonrandomly mixing population. Vaccines often have heterogeneous actions because of possible variation in the immune systems of hosts. One must consider such heterogeneity of vaccine action when developing a vaccine efficacy parameter. Addressing this issue the summary model of...

Longini, I.M.Jr; Sagatelian, K.; Rida, W.N.; Holloran, M.E.izabeth, 1998: Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations. Vaccination can have important indirect effects on the spread of an infectious agent by reducing the level of infectiousness of vaccinees who become infected. To estimate the effect of vaccination on infectiousness, one typically requires data on...

Yellowlees, A.; Perry, R.H.J., 2016: Estimating vaccine efficacy using animal efficacy data. Animal models are used to predict the effect of an intervention in humans. An example is the prediction of the efficacy of a vaccine when it is considered unethical or infeasible to challenge humans with the target disease to assess the effect of...

Kalchiem-Dekel, O.; Grupel, D.; Bouchnik, L.; Sikuler, E.; Ben-Yakov, G., 2016: Efficacy and long-term durability of intradermal recombinant hepatitis B virus vaccine among intramuscular vaccine nonresponders: A prospective study in healthcare personnel. Data on efficacy, safety, and durability of intradermal vaccine administration in persons who have not responded appropriately to intramuscular administration of hepatitis B virus (HBV) vaccine are relatively scarce. We designed a prospective case...

Longini I.; Haber M.; Chen R.; Halloran E.; Weierbach R.; Cotsonis G., 1990: A new approach for estimating vaccine efficacy. American Journal of Epidemiology 132(4): 802

Yağci, Münci.; Acar, K.; Sucak, Gülsan.Türköz.; Yamaç, K.; Haznedar, R., 2007: Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant. Hepatitis B virus (HBV) infection is effectively preventable by immunization with the commercially available recombinant HBV vaccines (HBV(vac)) in approximately 95% of healthy people. Immunosuppressive diseases like hematological malignancies are...

Longini, I.; Halloran, E.; Haber, M., 1995: Some current trends in estimating vaccine efficacy. Mollison, D [Editor] Publications of the Newton Institute; Epidemic models: Their structure and relation to data 394-403

Becker, N.G.; Britton, T., 2004: Estimating vaccine efficacy from small outbreaks. Let CV and C0 denote the number of cases among vaccinated and unvaccinated individuals, respectively, and let v be the proportion of individuals vaccinated. The quantity (e)over cap> = 1 - (1 - v)CV/(vC0) = 1 - (relative attack rate) is the mos...

Yang, Y.; Halloran, M.Elizabeth.; Chen, Y.; Kenah, E., 2016: A pathway EM-algorithm for estimating vaccine efficacy with a non-monotone validation set. Here, we consider time-to-event data where individuals can experience two or more types of events that are not distinguishable from one another without further confirmation, perhaps by laboratory test. The event type of primary interest can occur...

Davis, X.M.; Haber, M., 2004: Estimating vaccine efficacy from household data observed over time. Estimation of vaccine efficacy has traditionally focused on the reduction in susceptibility to infection, or the vaccine efficacy for susceptibility (VES). However, a vaccine, such as a prophylactic HIV vaccine, may also lower the infectiousness o...